Federal health regulators said at the end of Friday that the size of the size of children from the Covid-19 Pfizer vaccine looked very effective in preventing symptomatic infections in elementary school children and did not cause unexpected safety problems, because the US weighed initial vaccination in children .
Food and Medicine Administration posts Pfizer data analysis ahead of public meeting next week to debate whether the fire is ready for the country about 28 million children aged 5 to 11.
The body will ask the outside vaccine panel to choose the question.
In their analysis, FDA scientists concluded that in almost every scenario of vaccine benefits to prevent hospitalization and death from Covid-19 will be greater than serious potential side effects on children.
But body reviewers stopped calling for Pfizer shots to be authorized.
The agency will place the question to the independent adviser panel next Tuesday and weigh their advice before making your own decision.
If the FDA passes shots, control centers and prevention of disease will make additional recommendations about who should receive it in the first week of November.
Children can start vaccination early next month – with the first children in line protected fully by Christmas.
Full power pfizer shots have been recommended for anyone 12 or more, but the pediatrician and many parents anxiously await protection for younger children to sustain infections from extra-contagious Delta variants and help keep children in school.
The FDA review confirms the results of the previous pfizer posted today showed a two-dose shot nearly 91% effective to prevent symptomatic infections in children.
The researchers counted numbers based on 16 Covid-19 cases in children who were given a shot of dummy versus three cases among vaccinated children.
There are no severe diseases reported among any young people, but vaccinated have symptoms that are much lighter than their colleagues who are not vaccinated.
Most study data is collected at A.S.
During August and September, when the Delta variant has become the dominant Covid-19 tension.
The FDA review does not find new or unexpected side effects, which consists mostly of arms, fever or pain experiencing teenage experiences.
However, FDA scientists noted that this research was not large enough to detect very rare side effects, including myocarditis, a type of inflammation of the occasional heart after the second dose.
The agency uses statistical modeling to try to predict how much hospitalization and death of Covid-19 vaccines will prevent versus the number of heart side effects that can be caused.
Overall, the regulator concluded that the benefits of vaccine protectors’ `will be clearly greater than the side effects of the heart.
While children experience a lower risk of severe disease or death than parents, Covid-19 has killed more than 630 Americans 18 and below, according to the CDC.
Nearly 6.2 million children have been infected with Coronavirus, more than 1.1 million in the past six weeks because the Delta variant soared, said the American Pediatric Academy.
Biden administration has bought sufficient dose of child size in a special orange bottle to distinguish it from adult vaccines _ for children aged 5 to 11 years.
If the vaccine is cleaned, millions of doses will be sent immediately throughout the country, along with child size needles.
More than 25,000 pediatricians and primary service providers have registered to get a shot to the small arm.
FDA said the Covid Pfizer vaccine looks effective for young people
